Within-cell analyses in human-GLP1R-expressing neurons confirmed depolarization from baseline and a reduced time to spike threshold during current injection, indicating increased excitability following danuglipron application (Extended Data Fig
BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide, driving rising rates of cardiovascular disease, fatty liver disease, kidney complications and escalating healthcare costs
M., Thompson, D
Currently, NICE guidance (NG71) for Parkinson's disease does not recommend GLP-1 receptor agonists for treating this condition
Built for patients using GLP-1 medications, Pivot bridges the gap between prescription and daily adherence, delivering dose tracking, habit logging, and personalized insights that keep users consistent, informed, and motivated